Harbour Capital Advisors, LLC Abb Vie Inc. Transaction History

Harbour Capital Advisors, LLC

$415 Million
Q3 2024

A detailed history of Harbour Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 3,259 shares of ABBV stock, worth $586,620. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,259

Previous 3,259 -0.0%

Holding current value

$586,620

Previous $558,000 15.23%

% of portfolio

0.15%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $155,434 - $193,427	-1,173 Reduced 26.47%	3,259 $439,000
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $8,531 - $9,825	59 Added 1.35%	4,432 $706,000
Q4 2022 Jan 13, 2023	SELL	$138.31 - $165.87 $829 - $995	-6 Reduced 0.14%	4,373 $0
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $6,881 - $8,748	50 Added 1.16%	4,379 $671,000
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $19,577 - $22,223	184 Added 4.44%	4,329 $467,000
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $424,033 - $466,809	4,145 New	4,145 $448,000
Q4 2020 Jan 12, 2021	SELL	$80.49 - $108.67 $333,631 - $450,437	-4,145 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $318,468 - $373,776	-3,707 Reduced 47.21%	4,145 $363,000
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $188,560 - $252,322	-2,570 Reduced 24.66%	7,852 $771,000
Q1 2020 Apr 08, 2020	BUY	$64.5 - $97.79 $162,217 - $245,941	2,515 Added 31.81%	10,422 $794,000
Q4 2019 Jan 22, 2020	SELL	$72.13 - $90.25 $6,852 - $8,573	-95 Reduced 1.19%	7,907 $700,000
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $3,526 - $4,240	-56 Reduced 0.69%	8,002 $606,000
Q2 2019 Jul 10, 2019	SELL	$65.7 - $83.98 $10,840 - $13,856	-165 Reduced 2.01%	8,058 $586,000
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $18,513 - $21,789	-240 Reduced 2.84%	8,223 $663,000
Q4 2018 Jan 23, 2019	BUY	$77.85 - $96.01 $17,204 - $21,218	221 Added 2.68%	8,463 $780,000
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $16,537 - $18,384	186 Added 2.31%	8,242 $780,000
Q1 2018 Apr 18, 2018	SELL	$92.01 - $123.21 $91,273 - $122,224	-992 Reduced 10.96%	8,056 $763,000
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $105,770 - $115,986	-1,181 Reduced 11.55%	9,048 $875,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $714,495 - $912,631	10,229	10,229 $909,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.

Account

Harbour Capital Advisors, LLC Abb Vie Inc. Transaction History